Abstract
Ischemic preconditionining has been shown to trigger a signaling pathway by potentiating tyrosine kinase phosphorylation leading to the activation of p38 MAP kinase and MAPKAP kinase 2. Recently, the nuclear transcription factor, NFκB, was found to play a role in the signaling process. Since NFκB is a target of oxygen free radicals, we hypothesized that reactive oxygen species might play a role in the signaling process. To test this hypothesis, isolated rat hearts were perfused in the absence or presence of either dimethyl thiourea (DMTU), a OH· radical scavenger, or SN 50 peptide, a NFκB blocker. Hearts were then subjected to ischemic preconditioning by four repeated episodes of 5 min ischemia each followed by 10 min reperfusion. All hearts were then made globally ischemic for 30 min followed by 2 h of reperfusion. The results of our study demonstrated enhanced tyrosine kinase phosphorylation during ischemic preconditioning which was blocked by DMTU. DMTU also inhibited preconditioning mediated increased phosphorylation of p38 MAP kinase and MAPKAP kinase 2 activity. However, DMTU had no effect on the translocation and activation of protein kinase C (PKC) resulting from preconditioning. Preconditioning reduced myocardial infarct size as expected. This cardioprotective effect of preconditioning was abolished by both DMTU and SN 50. Preconditioning resulted in the nuclear translocation and activation of NFκB. Increased NFκB binding was blocked by both DMTU and SN 50. The results of this study demonstrate that reactive oxygen species play a crucial role in signal transduction mediated by preconditioning. This signaling process appears to be potentiated by tyrosine kinase phosphorylation resulting in the activation of p38 MAP kinase and MAPKAP kinase 2 leading to the activation of NFκB suggesting a role of oxygen free radicals as second messenger. Free radical signaling seems to be independent of PKC although PKC is activated during preconditioning process suggesting the role of two separate signaling pathways in ischemic preconditioning.
Similar content being viewed by others
References
Flack J, Kimura Y, Engelman RM, Das DK: Preconditioning the heart by repeated stunning improves myocardial salvage. Circulation 84: III369–III374, 1991
Tosaki A, Cordis GA, Szerdahelyi P, Engelman RM, Das DK: Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals and ion shifts in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 23: 365–373, 1994
Kimura Y, Iyengar J, Subramaman R, Cordis GA, Das DK: Myocardial adaptation by repeated short term ischemia reduces post-ischemic dysfunction. Basic Res Cardiol 87: 128–138, 1992
Asimakis GK, Inners-McBride K, Medellin G, Conti VR: Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physio 263: H887–H894, 1992
Schott RJ, Rohmann S, Braun ER, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66: 1133–1142, 1990
Li GC, Vasquez BS, Gallagher KP, Lucchesi BR: Myocardial protection with preconditioning. Circulation 82: 609–619, 1990
Maulik N, Das DK: Hunting for differentially expressed mRNA species in preconditioned myocardium. Annals NY Acad Sci 793: 240–258, 1996
Das DK, Moraru II, Maulik N, Engelman RM: Gene expression during myocardial adaptation to ischemia and reperfusion. Annals NY Acad Sci 723: 292–307, 1994
Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK: Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233–237, 1996
Das DK, Maulik N, Yoshida T, Engelman RM, Zu YL: Preconditioning potentiates molecular signaling for myocardial adaptation to ischemia. Annals NY Acad Sci 793: 191–209, 1996
Maulik N, Watanabe M, Tosaki A, Engelman DT, Engelman RM, Rousou JA, Deaton DW, Flack JE, Das DK: Tyrosine kinase regulation of phospholipase D-protein C kinase pathway in ischemic preconditioning. J Am Coll Cardiol 27: 385A, 1996
Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM: Reactive oxygen intermediates activate NF-Kappa B in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56 Ick and p59 fyn tyrosine kinases in human lymphocytes. Blood 82: 1212–1220, 1993
Das DK, Moraru II, Maulik N, Engelman RM: Gene expression during myocardial adaptation to ischemia and reperfusion. Annals NY Acad Sci 723: 292–307, 1994
Maulik N, Sato M, Price BD, Das DK: An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 429: 365–369, 1998
Engelman DT, Watanabe M, Engelman RM, Rousou JA, Kisin E, Kagan VE, Maulik N, Das DK: Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res 29: 133–140, 1995
Cordis GA, Maulik N, Das DK: Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol 27: 1645–1653, 1995
Yoshida T, Maulik N, Engelman RM, HO Y-S, Magnenat J-L, Rousou JA, Flack JE, Deaton D, Das DK: Glutathione peroxidase knockout mice are susceptible to nyocardial ischemia reperfusion injury. Circulation 96 (part 2): 216–220, 1997
Price BD, Calderwood SK: Ca2+ is essential for the heat shock factor in permeabilized cells. Mol Cell Biol 11: 3365–3368, 1991
Cohen MV, Liu Y, Liu G, Wang P, Weinbrenner C, Cordis GA, Das DK, Downey JM: Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 94: 1713–1718, 1996
Zu Y-L, Ai Y, Gilchrist A, Maulik N, Watras J, Sha'afi RI, Das DK, Huang C-K: High expression and activation of MAP Kinase activated protein kinase 2 in cardiac muscle cells. J Mol Cell Cardiol 29: 2150–2168, 1997
Maulik N, Yoshida T, Zu Y-L, Sato M, Banerjee A, Das DK: Ischemic stress adaptation of heart triggers a tyrosine kinase regulated signaling pathway. A potential role for MAPKAP kinase 2. Am J Physiol 275: H1857–H1864, 1998
Guyton KZ, Liu Y, Gorospe M, Xu Q: Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271: 4138–4142, 1996
Maulik N, Watanabe M, Engelman RM, Kagan VE, Kisin E, Tyurin V, Cordis GA, Das DK: Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiology (Cell Physiology) 269: C907–C916, 1995
Han J, Lee J-D, Tobias PS, Ulevitch RJ: Endotoxin induces rapid protein tyrosine phosphorylation in 70z/3 cells expression cD14. J Biol Chem 268: 25009–25014, 1993
Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ: MKK3–and MKK6–regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247–1255, 1996
Staal FJT, Roederer M, Herzenberg LA: Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87: 9943–9947, 1990
Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB: Tumar necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 86: 5974–5978, 1989
Yamazaki T, Seko Y, Tainatani T, Miyasaka M, Yagita H, Okumura K, Nagai R, Yazaki Y: Expression of intracellular adhesion molecule-1 in rat heart with ischemialreperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol 143: 410–418, 1993
Tosaki A, Bagchi D, Hellegouarch A, Pali T, Cordis GA, Das DK: Comparisons of ESR and HPLC methods for the detection of OH· radicals in ischemic/reperfused hearts. A relationship between the genesisof free radicals and reperfusion arrhythmias. Biochem Pharmacol 45: 961–969, 1993
Baker JE, Felix CC, Olinger GN, Kalyanaraman B: Myocardial ischemia and reperfusion: Direct evidence for free redical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci USA 85: 2786–2788, 1988
Das DK, Engelman RM, Kimura Y: Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischemia. Cardiovasc Res 27: 578–584, 1993
Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK: The role of protein kinase C in ischemic/reperfused preconditioning isolated rat hearts. J Cardiovas Pharmacol 28: 723–731, 1996
Toledano M, Leonard WJ: Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 86: 5974–5978, 1991
Meyer M, Schreck R, Baeuerle PA: H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005–2015, 1993
Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247–2258, 1991
Suzuki YJ, Mizuno M, Packer L: Signal transduction for nuclear factor-kappa B activation. Proposed location of antioxidant inhibitable step. Biochem Biophys Res Commun 210: 537–541, 1994
Bagchi D, Das DK, Engelman RM, Prasad MR, Subramanian R: Polymorphonuclear leucocytes as potential source of free radicals in the ischemia-reperfused myocardium. Eur Heart J 11: 800–813, 1990
Ghosh S, Gifford AM, Riviere LR, Tempst P, Nolan GP, Baltimore D: Cloning of the p50 DNA binding subunit of NF-kappa B: Homology to rel and dorsal. Cell 62: 1019–1029, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Das, D.K., Maulik, N., Sato, M. et al. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 196, 59–67 (1999). https://doi.org/10.1023/A:1006966128795
Issue Date:
DOI: https://doi.org/10.1023/A:1006966128795